Athletes' own blood may speed knee healing after ACL surgery
NCT ID NCT07257666
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether applying platelet-rich fibrin (PRF), a gel made from the patient's own blood, to the knee after ACL reconstruction can reduce numbness and improve function. Fifty-three male athletes were split into two groups: one received PRF during surgery, the other standard closure. The main goal was to see if PRF reduced sensory loss at the donor site one year after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
platelet-rich fibrin (PRF)
What this could lead to
If it works, this could point toward a simple way to improve recovery and reduce numbness after ACL surgery.
What could go wrong
This is a small, early pilot study with only 53 participants, so results may not apply to everyone. PRF is made from the patient's own blood, so risks are low but benefits are still unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE INJURIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Clinical Center of Serbia (UKCS)
Belgrade, 11000, Serbia